Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

This study has been completed.
Sponsor:
Collaborator:
Dutch Cancer Society
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT00602862
First received: January 3, 2008
Last updated: November 29, 2013
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
No publications provided by Radboud University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):